Key points are not available for this paper at this time.
The 24-week risk of Covid-19 outcomes was low after vaccination with mRNA-1273 or BNT162b2, although risks were lower with mRNA-1273 than with BNT162b2. This pattern was consistent across periods marked by alpha- and delta-variant predominance. (Funded by the Department of Veterans Affairs and others.).
Building similarity graph...
Analyzing shared references across papers
Loading...
Barbra A. Dickerman
Harvard University
Hanna Gerlovin
Boston University
Arin L. Madenci
Boston Children's Hospital
New England Journal of Medicine
Harvard University
Brigham and Women's Hospital
Boston University
Building similarity graph...
Analyzing shared references across papers
Loading...
Dickerman et al. (Wed,) studied this question.
synapsesocial.com/papers/69d5700275589c71d767db46 — DOI: https://doi.org/10.1056/nejmoa2115463
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: